Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: A pilot study

J. W. Han, J. S. Yoon, S. Y. Jang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

PurposeLong-standing prosthetic eye wearing induces ocular surface inflammation. We investigated the short-term effects of topical cyclosporine A 0.05% (Restasis) in patients with ocular discomfort resulting from long-standing prosthetic eye wearing.MethodsThis was a prospective, interventional case series. Patients who were unilateral prosthetic eye wearers over a period of 5 years were enrolled at a single institution from March to July 2013. The subjects were instructed to instill topical cyclosporine A 0.05% twice per day. Measurements were made pre-treatment and after 1 and 3 months of treatment. Outcome measures were the ocular symptom score, the lid margin abnormality score, the Schirmer test, and the tear meniscus amount, using Fourier-domain optical coherence tomography.ResultsIn total, 20 consecutive patients (mean age: 60.1 years, 8 males, 12 females) were included. Ocular symptoms were improved after treatment for 1 month in all patients (ocular symptom score pre-treatment 76.83 vs 46.75 after treatment; P<0.001). There was no statistically significant difference in lid margin abnormality score or tear meniscus amount. The Schirmer test results were improved after treatment for 3 months (pre- and after treatment, 6.70 vs 11.40; P<0.001).ConclusionsTopical cyclosporine A 0.05% showed a satisfactory effect in long-standing prosthetic eye wearers. Ocular symptoms were markedly relieved in all subjects after treatment for 1 month.

Original languageEnglish
Pages (from-to)1212-1217
Number of pages6
JournalEye (Basingstoke)
Volume28
Issue number10
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Cyclosporine
Therapeutics
Tears
Optical Coherence Tomography
Outcome Assessment (Health Care)
Inflammation

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems

Cite this

@article{b51aec97870d4a6ebe78ee90ed2feade,
title = "Short-term effects of topical cyclosporine A 0.05{\%} (Restasis) in long-standing prosthetic eye wearers: A pilot study",
abstract = "PurposeLong-standing prosthetic eye wearing induces ocular surface inflammation. We investigated the short-term effects of topical cyclosporine A 0.05{\%} (Restasis) in patients with ocular discomfort resulting from long-standing prosthetic eye wearing.MethodsThis was a prospective, interventional case series. Patients who were unilateral prosthetic eye wearers over a period of 5 years were enrolled at a single institution from March to July 2013. The subjects were instructed to instill topical cyclosporine A 0.05{\%} twice per day. Measurements were made pre-treatment and after 1 and 3 months of treatment. Outcome measures were the ocular symptom score, the lid margin abnormality score, the Schirmer test, and the tear meniscus amount, using Fourier-domain optical coherence tomography.ResultsIn total, 20 consecutive patients (mean age: 60.1 years, 8 males, 12 females) were included. Ocular symptoms were improved after treatment for 1 month in all patients (ocular symptom score pre-treatment 76.83 vs 46.75 after treatment; P<0.001). There was no statistically significant difference in lid margin abnormality score or tear meniscus amount. The Schirmer test results were improved after treatment for 3 months (pre- and after treatment, 6.70 vs 11.40; P<0.001).ConclusionsTopical cyclosporine A 0.05{\%} showed a satisfactory effect in long-standing prosthetic eye wearers. Ocular symptoms were markedly relieved in all subjects after treatment for 1 month.",
author = "Han, {J. W.} and Yoon, {J. S.} and Jang, {S. Y.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/eye.2014.174",
language = "English",
volume = "28",
pages = "1212--1217",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "10",

}

Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers : A pilot study. / Han, J. W.; Yoon, J. S.; Jang, S. Y.

In: Eye (Basingstoke), Vol. 28, No. 10, 01.01.2014, p. 1212-1217.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers

T2 - A pilot study

AU - Han, J. W.

AU - Yoon, J. S.

AU - Jang, S. Y.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - PurposeLong-standing prosthetic eye wearing induces ocular surface inflammation. We investigated the short-term effects of topical cyclosporine A 0.05% (Restasis) in patients with ocular discomfort resulting from long-standing prosthetic eye wearing.MethodsThis was a prospective, interventional case series. Patients who were unilateral prosthetic eye wearers over a period of 5 years were enrolled at a single institution from March to July 2013. The subjects were instructed to instill topical cyclosporine A 0.05% twice per day. Measurements were made pre-treatment and after 1 and 3 months of treatment. Outcome measures were the ocular symptom score, the lid margin abnormality score, the Schirmer test, and the tear meniscus amount, using Fourier-domain optical coherence tomography.ResultsIn total, 20 consecutive patients (mean age: 60.1 years, 8 males, 12 females) were included. Ocular symptoms were improved after treatment for 1 month in all patients (ocular symptom score pre-treatment 76.83 vs 46.75 after treatment; P<0.001). There was no statistically significant difference in lid margin abnormality score or tear meniscus amount. The Schirmer test results were improved after treatment for 3 months (pre- and after treatment, 6.70 vs 11.40; P<0.001).ConclusionsTopical cyclosporine A 0.05% showed a satisfactory effect in long-standing prosthetic eye wearers. Ocular symptoms were markedly relieved in all subjects after treatment for 1 month.

AB - PurposeLong-standing prosthetic eye wearing induces ocular surface inflammation. We investigated the short-term effects of topical cyclosporine A 0.05% (Restasis) in patients with ocular discomfort resulting from long-standing prosthetic eye wearing.MethodsThis was a prospective, interventional case series. Patients who were unilateral prosthetic eye wearers over a period of 5 years were enrolled at a single institution from March to July 2013. The subjects were instructed to instill topical cyclosporine A 0.05% twice per day. Measurements were made pre-treatment and after 1 and 3 months of treatment. Outcome measures were the ocular symptom score, the lid margin abnormality score, the Schirmer test, and the tear meniscus amount, using Fourier-domain optical coherence tomography.ResultsIn total, 20 consecutive patients (mean age: 60.1 years, 8 males, 12 females) were included. Ocular symptoms were improved after treatment for 1 month in all patients (ocular symptom score pre-treatment 76.83 vs 46.75 after treatment; P<0.001). There was no statistically significant difference in lid margin abnormality score or tear meniscus amount. The Schirmer test results were improved after treatment for 3 months (pre- and after treatment, 6.70 vs 11.40; P<0.001).ConclusionsTopical cyclosporine A 0.05% showed a satisfactory effect in long-standing prosthetic eye wearers. Ocular symptoms were markedly relieved in all subjects after treatment for 1 month.

UR - http://www.scopus.com/inward/record.url?scp=84927675213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927675213&partnerID=8YFLogxK

U2 - 10.1038/eye.2014.174

DO - 10.1038/eye.2014.174

M3 - Article

C2 - 25081289

AN - SCOPUS:84927675213

VL - 28

SP - 1212

EP - 1217

JO - Eye

JF - Eye

SN - 0950-222X

IS - 10

ER -